The underlying molecular mechanism include: (1) SGLT2 inhibition inhibited glucose uptake and glycolysis level, and inhibited AKT/mTOR activation and increased AMPK activation, which lead to decreased proliferation of thyroid cancer. This evidence concerns the gene MTOR and thyroid gland carcinoma.